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ABSTRACT: Passenger leukocytes have been demon-
strated to play significant roles in initiating and also 
regulating immune reactions after organ transplantation. 
Reliable techniques to detect donor leukocytes in recipi-
ents after organ transplantation are essential to analyze the 
role, function, and behavior of these leukocytes. In this 
report we describe a simple, reliable method to detect 
donor cells with low frequencies using peripheral blood 
samples. Detection of small numbers of major histocom-
patibility complex (MHC) mismatched cells was first 
studied using four-color flow cytometry in artificially 
created cell mixtures. By selecting the CD45 + population 
and simultaneous staining with several leukocyte lineage 
markers (CD3, CD4, CDS, CD56, and CD19), MHC-
mismatched leukocytes were consistently detected in cell 
suspensions prepared from directly stained whole blood 
samples with a threshold sensitivity as low as D.I %~ 
ABBREVIATIONS 
mAb monoclonal antibody 
PBMC peripheral blood mononuclear cells 
WB whole blood 
INTRODUCTION 
Passenger leukocytes in solid organ allografts have been 
conventionally considered to be the main initiators of 
immune reactions leading to allograft rejection (1, 2). 
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0.2%. When the fresh peripheral blood mononuclear cells 
were separated by conventional Ficoll gradienr purifica-
tion, similar, but slightly lower levels of donor cells were 
detected. Blood samples obtained I ~ 5 months after liver, 
kidney, and intestine transplants revealed that the kind of 
organ allograft influenced levels and lineage pattern of the 
circulating donor cells. This procedure provided a simple 
and reliable method in determining early chimerism in 
transplant recipients. However, the detection of MHC-
mismatched leukocytes of all lineages was much lower 
when frozen peripheral blood mononuclear cells were 
used. Human Immunology 64, 787~795 (2003), © 
American Society for Histocompatibility and Immunoge-
netics, 20D3. Published by Elsevier Inc. 
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However, the persistence of small numbers of donor 
leukocytes in the recipient for decades after transplanta-
tion implies the possible function of these cells as active 
modulators for graft acceptance (3, 4). The persistence of 
mobile donor alloantigens, with sustained immune reac-
tions between donor and recipient leukocytes, and con-
sequent mutual immunologic regulation, are considered 
to be the principal factors for allograft acceptance (5, 6}. 
The analysis of the role, function, and behavior of 
donor leukocytes after transplantation requires sensitive 
techniques to distinguish donor and recipient phenotype 
cells. The detection of small numbers of donor cells long 
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after ttansplantation has only recently become possible. 
Currently, donor cells are analyzed by polymerase chain 
reaction (PCR), immunohistochemistry, in-situ hybrid-
ization, and flow cytometry by targeting disparities at 
the human leukocyte antigen (HLA) loci or sex-deter-
mining region Y [4, 7-9}' Some of these techniques are 
either laborious or require particular tissue samples, 
thereby precluding their widespread use. Flow cytomet-
ric analysis is technically simple and the procedure can be 
completed in a short time. Although this method has 
been known to have limitations in detecting low fre-
quency events, it could provide valuable information on 
surface or intracellular expression of various molecules on 
donor cells. Therefore, it was our goal to establish a 
standardized flow cytometric technique that can provide 
reliable results of donor leukocytes after organ transplan-
tation in a timely manner. 
In this report we describe a four-color flow cytometry 
method to detect levels and lineages of major histocom-
patibility complex (MHC) mismatched (donor) cells using 
variable types of samples, including whole blood, and fresh 
and frozen peripheral blood mononuclear cells (PBMC) 
from normal volunteers, artificial mixtures, and samples 
from organ transplant recipients. The method is quick and 
reliable, with a detection limit of 0.1 %-0.2% when used 
in combination with lineage-specific antibodies. 
MATERIALS AND METHODS 
Blood Collection and Processing 
Heparinized whole blood (WB) was obtained from 
healthy volunteers and transplant recipients in accor-
dance with the guidelines of the Institutional Review 
Board at the University of Pittsburgh. Three types of 
blood samples were used in this study: WB, freshly 
isolated PBMC, and cryopreserved PBMC. PBMC were 
obtained by Ficoll-Hypaque (Amersham Pharmacia Bio-
tech, Piscataway, NJ, USA) standard density gradient 
centrifugation method [l0}. Aliquots of PBMC were 
cryopreserved in freezing medium containing 10% 
DMSO and 30% FCS in RPMI 1640 (Life Technologies, 
TABLE 1 Monoclonal antibodies used in the study 
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Grand Island, NY, USA), in liquid nitrogen, and thawed 
rapidly for assay in a 37 DC water bath. 
HLA Typing 
HLA typing was performed at the Tissue Typing Labo-
ratory (Clinical Immunopathology, Central Laboratory 
Services, Inc., University of Pittsburgh Medical Center, 
Pittsburgh, PA, USA) using genomic DNA extracted 
from PBMC isolated from all patients in the study. 
Artificial Mixtures 
Whole blood or isolated PBMC from healthy volunteers 
were mixed in vitro to generate the artificial samples 
containing known levels of HLA-mismatched and sex-
mismatched cells (5%,1%,0.3%, and 0.1%). Aliquots 
of PBMC mixtures were cryopreserved and used in par-
allel with WB mixtures or fresh PBMC mixtures for 
comparison analysis. 
Antibodies and Reagents 
The panel of FITC-conjugated monoclonal antibodies 
(mAb) specific for HLA-A or -B loci were either pur-
chased from One Lambda, Inc. (Canoga Park, CA, USA) 
or prepared from hybridomas (A TCC, Manassas, VA, 
USA) and FITC-conjugated at the University of Pitts-
burgh Cancer Institute Hybridoma Facility, directed by 
Dr. Albert Deleo. Other lineage-specific mAbs included 
CD3-PE, CD4-PE, CD56-PE, CD19-PC5, CD8-PC5, 
and CD45-ECD (Beckman Coulter Co., Miami, FL, 
USA, and Becton-Dickinson, San Jose, CA, USA). Flu-
orochrome-conjugated isotype-matched non-specific 
mAbs were used as negative controls for each assay. 
Flow Cytometric Analysis 
Whole blood (100,....1) was incubated with relevant mAbs 
or isotype controls for 20 minutes in dark at 4 DC, and 
then mixed vigorously with FACS lysing solution (Bec-
ton Dickinson) for 10 minutes at room temperature for 
erythrolysis and fixation. Cells were washed twice and 
fixed in 1% paraformaldehyde in PBS. Alternatively, 
freshly isolated or frozen PBMC (1 X 105 cells) were 
Specificity Isotype Dilution Supplier 
A2/28 
A3 
A9 
B7 
B8 
B12 
B27 
mouse IgG2a 
mouse IgG2a 
mouse IgG2b 
mouse IgG1 
mouse IgG2b 
mouse IgG2b 
mouse IgG1 
* Based on the mAb concentrations of 1 mg/ml. 
1:300 
1:20* 
1:20 
1:30* 
1:20 
1:20 
1:20 
One Lambda, Inc. 
ATCC (HB122)/UPCI Hybridoma Facility 
One Lambda, Inc. 
ATCC (HB56)/UPCI Hybridoma Facility 
One Lambda, Inc. 
One Lambda, Inc. 
One Lambda, Inc. 
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FIGURE 1 Detection of major histocompatibility complex 
(MHC) mismatched cells in different artificial mixtures. 
Whole blood from normal volunteers who were mismatched at 
human leukocyte antigen A (HLA-A) were mixed to generate 
1%, 0 . .3%, and 0.1% artificial mixtures. Level and lineage 
specificity of MHC-mismatched (HLA-A2) cells were analyzed 
on gated CD45 (ECD) positive cells with monocloml antibod-
ies for HLA-A2 (FITC), together with CD.3 (PE) and CD19 
(PE). 
preincubated with 10% goat serum for 20 minutes for 
the blocking of nonspecific binding, washed three times, 
and incubated for 20 minutes in dark at 4 °C with 
relevant mAbs or isotype controls, followed by washing 
and fixation. A typical four-color flow cytometry analysis 
was performed with mAb combinations of CD45-ECD, 
anti-HLA-FITC, and two leukocyte lineage markers con-
jugated with PE and PE-Cy5. Data acquisition and anal-
ysis was performed on a Coulter EPICS XL flow cytom-
eter (Beckman Coulter Co.) mounted with four 
photomultiplier tubes and a single argon laser. In a 
conventionally selected lymphocyte cluster, using side-
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scatter (SS) versus forward-scatter (FS) cytograms, 50,000 
CD45 + events were collected per sample and analyzed 
with EXP032 software (Applied Cytometry System, 
Sheffield, United Kingdom). Daily calibration of the 
instrument was performed using flow check fluoro-
spheres (Beckman Coulter Co.). Fluorescent compensa-
tion was performed using a normal control and staining 
with each fluorochrome separately. Compensation values 
were set to eliminate spectral overlap. 
Cytospin and Fluorescent In Situ Hybridization 
for XY 
Aliquots of 1 X 105 cells from WB or PBMC were 
cytospun for 5 minutes at 500 rpm using a centrifuge 
(Thermo Shandon, Pittsburgh, P A, USA). The slidES 
were air dried and fixed in 95% ethanol for 10 minutes. 
FISH analysis was carried out using directly labeled 
probes for X (red) and Y (greC'i1) chromosome alfa-satel-
lite regions, according to the manufacturer's recom-
mended protocol (Vysis Inc., Doweners Grove, IL, USA). 
The slides were counterstained with DAPI (125 mg/ml) 
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FIGURE 2 Comparison of blood sample types. Artificial 
mixture (0.)%) prepared in whole blood (WB) was further 
processed to obtain fresh peripheral blood mononuclear cells 
(FBMC) and frozen PBMe. Different types of samples were 
stained as described in methods section. (A) Levels of human 
leukocyte antigen (HLA) mismatched (HLA-A3) cells are re-
liably detected in WB and fresh FBMe. (B) Frozen PBMe: 
demonstrate significantly decreased percentages of lILA-mis-
matched cells (HLA-B8), compared with fresh PBMe. Results 
are of one representative experiment out of three performed. 
and analyzed under florescent microscope. At least 300 
hybridized nuclei with two signals (XX or XY) were 
examined on each slide. 
PCR Analysis 
DNA isolated from peripheral blood samples was ampli-
fied using probes directed against HLA-DR or Y chro-
mosome and resolved by electrophoresis on agarose gels. 
PCR products were analyzed with Southern Blotting by 
hybridizing the membrane with specific radiolabeled 
B 
PBMC fresh 
0.3% 
0.02 
0.11 
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PBMe frozen 
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probes and exposing to the film. The technique detects 
one donor cell within 10,000 recipient cells. 
RESULTS 
MAb Selection and Titration 
A panel of seven mAbs, specific for HLA-A and -B loci, 
were examined in this study (Table l). Using these 
mAbs, it was theoretically possible to analyze donor 
phenotype leukocytes in > 70% of organ transplant 
recipients in this center (ll}. Each mAb was initially 
tested for its specificity in WB and PBMe samples 
obtained from normal volunteers of known HLA haplo-
types using at least four different mAb dilutions. The 
working concentration was determined as the highest 
dilution of the mAb that gave the strongest binding 
signal in positive HLA-matched patients, and minimal 
or no background binding to the samples that did not 
express particular HLA of interest. 
For the two mAbs purified and FITC-conjugated at 
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FIGURE 3 XY flu orescent it! Slill hybridizarion (FISH) 
Cycospin slides were creared from artificial mixtutes (male 
0.3 % and female 99.7% ) of whole blood and fresh peripheral 
blood mononuclear cells (PBMC) samples Llsed in Figure 1 and 
2A, and analyzed with XY FISH. Arrow indi cates male cell 
wirh Y hybridizarion sig nal (green) among female cells of twO 
X (red) hybridization signals. This is one representar ive exper-
iment our of several performed. 
rhe UPMC hybridoma facility (anri-A3 and anri-Bn 
three fluorochrome-to-protein ratios 0:10, 1:20, and 
1 :40) were initially tested to select the producr with the 
highest staining intensity (data not shown). Once the 
appropriate fluorochrome-mAb ratio was determined, 
la rge quanrities of mAb were prepared . Titration bind-
ing studies were repeated for each new batch of mAbs. 
Most of mAbs were proven to have satisfactory binding 
specificity and were used for further analyses. 
Comparison of Chimerism in Arrificial Mixtures, 
WB, Fresh PBMC, or Frozen PBMC 
To examine the limirarion of flow cytometry in detecting 
small numbers of HLA-mismatched leukocytes in blood 
samples, artificial mixtures were creared in WB samples 
and analyzed with four-color flow cytometry (Figure 1). 
\Xfhen the mixture contained 1% or 0.3 % of HLA-
mismatched cells, they were, as expected, easily idenri-
fied. In 0 1 % artificial mixture, mismatched cells could 
not be accurately distinguished from the nonspecific 
binding with isorype controls, suggesting that the 
threshold sensitivity of the assay using WB resides 
around 0.1 %-0.2% . Using multicolor analysis with lin-
eage markers, existence of CD3 + (CD4 + and CDS+) or 
CD19+ HLA-mismarched cells appeared to be particu-
lady helpful to distinguish positive events ftom nonspe-
cific binding. 
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We next examined whether levels of chimerism and 
detection threshold in WB samples could be alteted in 
PBMC during isolation and freezing procedures. An 
artificial mixtUre (0.3 %) was created in WB, and PBMC 
were isolated. Portions of PBMC were cryopreserved and 
later thawed for analysis and displayed as dot plot with 
SS versus FS. The cytograms with WB and PBMC sam-
ples were different. WB samples contained all three main 
clusters of lymphocytes, monocytes, and polymorphonu-
clear granulocytes. As expected, isolated PBMC were 
mainly lymphocytes and monocytes without granulocyte 
clusters (Figure 2A). To examine whether HLA-mis-
matched (donor) cells could be lost during PBMC isola-
tion procedure, mismarched cells (03 %) in original WB 
samples were backgated for their location in SS vs. FS dot 
plots. HLA-mismatched cells were found in all three cell 
clusters in WB samples, with different disrributions 
(40%-50% in lymphocytes, 20%-40% in monocytes, 
and 10% in granulocytes). However, when cells in the 
lymphocyte cluster were analyzed, WB and PBMC sam-
ples exhibited similat levels of mismatched cells, sug-
gesting that there was little, if any, loss of lymphocytes 
during Ficoll-Hypaque isolation process , although the 
majority of granulocytes were elimi nated. In contrast, 
TABLE 2 Frequency of chimerism in organ 
transplant recipients using four-color 
flow cytometry 
Number 30-60 Days 60-150 Days 
Kidney 44 1)'* U/23) 0'11: (O/l4) 
Liver l5 62'X (5/8) .03'X (41l 2) 
Inces rjne 10 80 'l[ (4 /5) 66'?{ (4 /6) 
Tora) 69 33 % (12/ 36) 2Y;: (8 /3 2) 
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FIGURE 4 Donor cells in liver and intestine transplant 
patients early after transplantation. Whole blood obtained at 
i-month after intestine and liver transplantation were stained 
with monoclonal antibodies for CD45 (ECD), HLA-A2 or -A3 
(FITC) and CD3 (PE), CD4 (PE) and CD19 (PC5). 
when frozen PBMC were thawed and analyzed with a 
comparison to fresh PBMC, the percentage of HLA-
mismatched cells was reduced compared with the origi-
nal artificial mixture of 0.3% (Figure 2B). These results 
indicate that significant numbers (i.e., half) of HLA-
mismatched cells may be lost during freeze/thaw pro-
cesses. 
In parallel to flow cytometry, cytospin slides were 
created from the same artificial mixture samples (0.3%) 
of WB and fresh PBMC for XY FISH. Figure 3 illus-
trates the presence of one male donor cell among many 
female recipient cells with a ratio of 1:300, confirming 
the result of flow cytometry. Importantly, Ficoll-
Hypaque isolated PBMC in the cytospin preparation 
revealed cell fragmentation and enhanced adherence, 
making cell visualization difficult. In contrast, cytospin 
slides prepared from WB samples demonstrated intact 
cell morphology. 
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Studies of Organ Recipients 
A total of 69 consented recipients of kidney (n = 44), 
liver (n = 15), and intestine/multivisceral (n = 10) grafts 
transplanted between July 2001 and November 200l 
were prospectively analyzed for chimerism using periph-
eral blood samples obtained during 1-5 months post-
transplantion. Patients were conditioned with pretrans-
plant thymoglobulin (5 mg/kg) and treated 
postoperatively with minimal tacrolimus-based immu-
nosuppression [l2}. Donor splenocytes and pretransplant 
recipient blood samples were used as positive and nega-
tive controls, respectively. Four-color flow cytometry in 
WB samples was performed in 48 of 69 recipients. PCR 
was also performed in 47 of 69 patients to detect low-
level chimerism. Thirty-eight patients were tested with 
flow cytometry and PCR in parallel (i.e., same samples). 
Nine kidney recipients were not analyzed with either 
method due to zero HLA antigen mismatches (n = 5) or 
lack of available anti-HLA mAbs or probes. 
Characteristics of Peripheral Blood Chimerism 
Frequency and level. The kind of allograft was a prime 
determinant of the frequency and level of early chimer-
TABLE 3 Blood samples analyzed for chimerism with both flow cytometry and PCR 
Number 
Kidney 44 
Liver 14 
Intestine 10 
Total 69 
peR = polymerase chain reaction. 
Flow+ PCR+ 
9% (2/23) 
45';'f (5111) 
50% (2/4) 
24% (9138) 
Flow- PCR+ 
17% (4/23) 
9% (III 1) 
25% (1/4) 
16% (6/38) 
Flow- PCR-
74%(17/23) 
45<;1 (5111) 
25% (111) 
60% (23/38) 
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FIGURE 5 Donor cells decrease with time after transplan-
tation. Four-color flow cytometric analyses of a liver patient at 
1- and 3-months after transplantation demonstrate the dynam-
ics of donor cells with time. Anti-HLA-A3 (FITC) together 
with anti-CD) (PE), -CD4 (PE), and -CDI9 (PE) monoclonal 
antibodies were used to detect donor cells and their lineage 
specificity, 
ism [4, 13, 14}. Between 30 and 60 days macrochimer-
ism was detected by flow cytometry in 62 % and 80% of 
liver and intestine recipients, respectively. In contrast, 
only 13% of kidney recipients had macrochimerism (Ta-
ble 2). The percentages of donor cells ranged from 0.2%-
4.0% in this early period. 
Between 60 and 150 days both the incidence and level 
of macrochimerism waned, particularly in the kidney 
recipients who had an incidence of zero. In contrast, :33% 
of liver and 66% of intestine recipients remained mac-
rochimeric with levels of 0.2%-0.8% (Table 2). The 
results were consistent with previous observations in rats 
[IS} and in humans [l6} that early chimerism dimin-
ishes with time and becomes undetectable by six months 
in most organ recipients. 
In early and late samples that were analyzed with flow 
cytometry as well as PCR, chimerism was detected by 
both methods in 45% and 50% of liver and intestine 
recipients, respectively, whereas chimerism in kidney 
recipients could be detected mainly by PCR (Table 3). 
Lineages. The majority (> 90%) of donor cells in intes-
tine recipients were CD3 +, with a distribution in both 
CD4'- and CDS + populations (Figure 4). Donor B cells 
(CD19+) or natural killer (NK) cells (CDS6+) were also 
detected, but at a much lower frequency, In contrast, the 
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CD3 + and CD3- cells of donor phenotypes in liver 
recipients were nearly equal (Figures 4 and 5). The 
CD3 - cells included small numbers of donor Band NK 
cells and a large fraction that was not stained with any 
lineage marker, suggesting the presence of immature or 
undifferentiated cells. Although levels of chimerism de-
clined with time, the lineage profile of donor cells 10 
general was not significantly different (Figure 5). 
DISCUSSION 
With our use of four-color flow cytometry, HLA-mis-
matched donor cells in the peripheral blood samples of 
organ recipients can be reliably detected at frequencies as 
low as 0.1 %-0.2%. The assay incorporates several ways 
of improving its dependability and quality: 1) the rig-
orOLlS selection of mAbs that have high specificity for the 
particular HLA and low nonspecificity; (2) discriminat-
ing selection of CD45 + leukocytes for analysis; and (3) 
simultaneous staining with leukocyte lineage specific 
mAbs that delineate subpopulations while differentiat-
ing nonspecific background staining from genuinely pos-
itive staining. 
Below some levels of HLA-mismatched cells, methods 
other than flow cytometry must be used for the detection 
of microchimerism (e.g., PCR or in-Jitt! hybridization). 
One of the goals of our study was to define the cutoff 
point above which results of flow cytometry were reli-
able. In addition, to be useful, it was important for the 
method to be rapid, simple, and applicable for the study 
of large numbers of recipient blood samples. We limited 
our patient studies to the early period after transplanta-
tion, in part because of the availability of patient samples 
during this interval. In addition, immune events soon 
794 
after transplantation have been reported to have the most 
significant impact on long-term graft outcome [5}. 
Previous studies during this early post-transplant pe-
riod have been with a cocktail of mAbs of different HLA 
specificities (donor and recipient specificities) that were 
reported to detect levels ofHLA-mismatched cells as low 
as a frequency of 1 per 10,000 [l7}. The foregoing 
method may be applicable, however, only for the study of 
a few selected reports with particular HLA mismatches. 
Other flow cytometry studies have not been this sensitive 
[lS-20}. 
It was clear from the experiment demonstrating a 
significant decrease of donor cells in frozen compared 
with fresh PBMC samples that the study of frozen PBMC 
is not an ideal way to determine the presence or extent of 
donor leukocyte chimerism. Because freezelthaw proce-
dures routinely result in the loss of certain numbers of 
cells, it is reasonable to assume that a small population of 
donor cells could be brought below the detection thresh-
old by the freezing procedure. In another comparison, 
donor cells were more frequently detected in blood sam-
ples from liver and intestine recipients than from the 
blood of kidney recipients [4, 7, 14}. As high as 3%-4% 
of CD45 + circulating leukocytes were donor-phenotype 
30-days after intestinal and liver transplantation. In in-
testinal recipients, > 95% of donor cells were CD3 + 
(CD4 and CDS) T cells, whereas the CD3 + cells in liver 
recipients made up only 50% of the donor cells. The 
remaining CD3 - fraction contained a significant num-
ber of cells that were not stained with lineage-specific 
mAbs for CD3, CD19, or CD56. Several experimental 
studies have reported that the liver contains heteroge-
nous leukocyte subsets: immature dendritic cells [21, 
22}, immature B cells [23]' and NK T cells {:24}. Al-
though some authors have attributed tolerogenic prop-
erties to these cells, further studies will be needed to 
determine if such "lineage negative" have a special role in 
tolerance induction. 
With the flow cytometry technology, the majority of 
chimeric cells were found early after transplantation 
within the lymphocyte cluster (60%-70%), with few 
donor cells in the monocyte or granulocyte gates (10%-
20%). This could suggest either that organ-based leuko-
cytes do not contain a large number of granulocytes, or 
that granulocytes have a short survival time. However, 
the most likely explanation for the dominant presence of 
donor lymphocytes in blood is their rapid proliferation, 
that is, in a graft-versus-host reaction [3, 5, 6} which 
occurs in SCID mouse recipients of human PBMC infu-
sion {25}. 
In summary, the study describes the simple and reli-
able four-color flow cytometry method to detect HLA-
mismatched donor cells with a threshold sensitivity of 
0.1%-0.2%. The method may be useful in monitoring 
D. Metes et al. 
the donor cells during the critical early post-transplant 
period and studying their impact on long-term graft 
outcome. 
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